Pharmaceutical preparations and dietary supplements which reduce the carcinogenic effect of substances found in alcoholic beverages, tobacco, and fermented foods; Pharmaceutical preparations and dietary supplements for the prevention of gastrointestinal cancers; Pharmaceutical preparations and dietary supplements for the treatment and management of gastrointestinal diseases and disorders; Pharmaceutical preparations and dietary supplements for the treatment and management of symptoms associated with rheumatoid, cardiovascular and mutagenic disorders such as intestinal metaplasia; Pharmaceutical preparations and dietary supplements which when orally administered or topically applied, aid in the healing and prevention of changes of cells to malignancy; Pharmaceuticals in oral, intranasal or transdermal dosage forms that provide controlled release of the active ingredients used to treat gastrointestinal diseases and disorders; Pharmaceutical preparations and dietary supplements to be used for an achlorhydric and low-acid stomach caused by atrophic gastritis; Pharmaceutical preparations and dietary supplements to be used for Helicobacter pylori infection and autoimmune diseases; Pharmaceutical preparations and dietary supplements to be used for the reduction of gastric acid secretion; Pharmaceutical preparations and dietary supplements to be used to assist in recovery from stomach surgery; Pharmaceutical preparations and dietary supplements to be used in people with gene mutation affecting acetaldehyde metabolism; Amino acid supplements for the promotion of general maintenance of health.
REGISTERED
on 09 Aug 2016
ALDESOLVE
EXZELL PHARMA INC.
1671692 · 07 Apr 2014
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations and dietary supplements which reduce the carcinogenic effect of substances found in alcoholic beverages, tobacco, and fermented foods; Pharmaceutical preparations and dietary supplements for the prevention of gastrointestinal cancers; Pharmaceutical preparations and dietary supplements for the treatment and management of gastrointestinal diseases and disorders; Pharmaceutical preparations and dietary supplements for the treatment and management of symptoms associated with rheumatoid, cardiovascular and mutagenic disorders such as intestinal metaplasia; Pharmaceutical preparations and dietary supplements which when orally administered or topically applied, aid in the healing and prevention of changes of cells to malignancy; Pharmaceuticals in oral, intranasal or transdermal dosage forms that provide controlled release of the active ingredients used to treat gastrointestinal diseases and disorders; Pharmaceutical preparations and dietary supplements to be used for an achlorhydric and low-acid stomach caused by atrophic gastritis; Pharmaceutical preparations and dietary supplements to be used for Helicobacter pylori infection and autoimmune diseases; Pharmaceutical preparations and dietary supplements to be used for the reduction of gastric acid secretion; Pharmaceutical preparations and dietary supplements to be used to assist in recovery from stomach surgery; Pharmaceutical preparations and dietary supplements to be used in people with gene mutation affecting acetaldehyde metabolism; Amino acid supplements for the promotion of general maintenance of health.
Pharmaceutical preparations and dietary supplements which reduce the c...